During the past decade, University of North Carolina at Asheville conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina at Asheville" #1 collaborator was "Braini LLC" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator, "University of North Carolina" with 1 trials as a collaborator, "University of North Carolina at Asheville" with 1 trials as a collaborator and "University of South Alabama" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina at Asheville" are "Attention-Deficit/Hyperactivity Disorder" (1 trials), "Brain Health" (1 trials), "Cognitive Function" (1 trials) and "Memory" (1 trials). Many other conditions were trialed in "University of North Carolina at Asheville" in a lesser frequency.

Most popular intervention types in "University of North Carolina at Asheville" are "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Braini" (1 trials), "Neurofeedback treatment" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina at Asheville" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of North Carolina at Asheville". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of North Carolina at Asheville, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina at Asheville, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".